REG - Allianz Tech Trust - Directorate Change

Allianz Technology TrustAnnouncement

03/12/2024 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241203:nRSC6680Oa&default-theme=true

RNS Number : 6680O  Allianz Technology Trust PLC  03 December 2024

LEI: 549300OMDPMJU23SSH75

Allianz Technology Trust PLC

 

 

3 December 2024

 

 

 

Allianz Technology Trust PLC

Board Appointment

 

The Board is pleased to announce the appointment of Lucy Costa Duarte as a
Non-Executive Director of Allianz Technology Trust PLC with effect from 1
January 2025.

 

Lucy is a specialist in marketing strategy and investor relations in the
investment trust sector. Formerly a director at Citigroup, heading the
emerging markets ECM team in London, she left Citigroup in 2007 and took a
career break. Since 2016, she has been running the marketing and investor
relations functions of International Biotechnology Trust plc in a part time
capacity, initially at SV Health Investors and more recently at Schroders
following the trust's move to Schroders in 2023. She holds a BA (Hons) in
Modern Languages from the University of Durham.

 

Lucy will be a member of the Audit and Risk, Management Engagement,
Remuneration and Nomination Committees on appointment.

 

Tim Scholefield said:

"I am delighted that Lucy is joining our Board. She brings a wealth of
marketing and investor relations experience, and we all look forward to
working with her."

 

Lucy is a non-executive director of MIGO Opportunities Trust plc and Fidelity
Asian Values plc. There are no other details requiring disclosure in respect
of this appointment under paragraph 6.4.8 of the UK Listing Rules of the FCA.

 

For further information please contact:

 

Kelly Nice

Company Secretary

020 3246 7475

 

Stephanie Carbonneil

Managing Director

Head of Investment Trusts

Allianz Global Investors

020 3246 7256

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABRBDDIGGDGSX